Sinkove

待核實
待核實
Sinkove generates synthetic biomedical images using AI to accelerate clinical research.
官網Contact for PricingPaidFree Trial
前往官網
綜合評分
(0 則評價)
sinkove.com/
Sinkove website screenshot
Sinkove 是什麼?

Sinkove leverages generative AI to create high-quality synthetic biomedical images, reducing bias and accelerating clinical research and healthcare AI innovation. It addresses the limitations of traditional radiology data by providing AI-powered digital twin technology that generates synthetic patient datasets tailored to specific needs. This eliminates data scarcity, bias, and in

Sinkove generates synthetic biomedical images using AI to accelerate clinical research.

核心功能
AI-powered generation of synthetic biomedical images
Customizable AI models for specific datasets and requirements
Generation of diverse and realistic imaging across disease subtypes
Validation of synthetic data for accuracy and regulatory compliance
Seamless integration with existing research workflows
熱門使用情境
  • Accelerating research timelines by generating high-quality imaging datasets in seconds.
  • Eliminating data bias and improving diversity in imaging datasets.
  • Standardizing imaging data across different scanners and protocols.
  • Reducing the high costs of patient recruitment for clinical trials.
功能比較
基於工具方提供的資訊進行功能比較。
待核實
比較資訊僅供參考,請以官方網站的最新資訊為準。
如何使用
  • To use Sinkove
  • you can customize their pre-trained AI to your proprietary datasets and requirements
  • generate digital twins for diverse imaging
  • validate the synthetic data
  • and seamlessly integrate the AI-generated datasets into your existing research workflows. You can also get started for free or book a demo.
定價
Sinkove 採用 Paid 定價模式,價格與功能可能隨時間調整。
Free
$0
待核實
Pro
待核實
待核實
Team
待核實
待核實
Enterprise
待核實
待核實
優惠 / 優惠碼
目前沒有優惠碼。
大家喜歡它的原因
目前還沒有評價標籤。
還有哪些可以改進
目前還沒有評價標籤。
常見問題

驗證資訊
工具狀態
待核實
定價已核驗
待核實
創辦人已認領
否 / 待核實
來源
官網 / 社群提交
相關標籤
AI WritingContent GenerationResearchEmail WritingSummarizationRewritingAcademic Research瀏覽器擴充功能Freemium
你是這個工具的官方團隊嗎?
認領這個資料頁後,你可以更新產品資訊、定價與官方回覆。